N/A N=30 Barriers to Adherence to Recommended Follow-up in Women With a History of Gestational Diabetes
Gestational Diabetes Mellitus
Primary: Weight Loss — 0; 0; 2 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=66 Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women
Diabetes Prevention in Women After GDM Who Are at High-risk
Primary: Change in Body Weight — -21.5; -12.5; -4.4 kilograms — p=<0.032
Phase 3 N=153 Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Gestational Diabetes Mellitus · Type 2 Diabetes Mellitus · Metabolic Syndrome
Primary: Insulin Secretion-Sensitivity Index (IS-SI) — 418.4; 333 index — p=<0.04
Phase 4 N=36 Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM
Disorder of Glucose Regulation
Primary: Normalization of Glucose Levels — 9; 2; 4 Participants — p=.035
N/A N=95 Early Screening and Treatment of Women With Prediabetes in Pregnancy
Diabetes · Pregnancy
Primary: Number of Patients With a Diagnosis of Gestational Diabetes at 26 Weeks Gestation. — 19; 23 Participants — p=0.32
N/A N=18 Sleep Duration in Women With Previous Gestational Diabetes
Gestational Diabetes
Primary: Changes in Fasting Glucose — 10.4; 1.6 mg/dL
N/A N=195 De Por Vida: A Diabetes Risk Reduction Intervention for Hispanic Women
Diabetes · Weight Loss · PreDiabetes
Primary: Weight in Kilograms — 87.1; 86.3; 84.4; 85.9 kilograms — p==.001
Phase 4 N=114 Metformin Postpartum for GDM RCT for Reduced Weight Retention
Diabetes, Gestational
Primary: Weight Change — 6.5; 6.3 kg
Phase 4 N=54 Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus
Gestational Diabetes · Diabetes, Gestational · Pregnancy in Diabetes
Primary: Proportion of Women Who Are Eligible, Screened, Enroll and Remain in the Study — 25; 26 Participants — p=0.9
N/A N=958 Gestational Diabetes Mellitus Trial (GDM)
Diabetes, Gestational
Primary: Number of Participants With Composite Neonatal Morbidity — 149; 163; 62; 55 Participants — p=0.14
N/A N=12 Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes
Diabetes, Gestational · Gestational Weight Gain · Postpartum Weight Retention
Primary: Number of Meals Successfully Ordered and Delivered — 2880 meals
N/A N=962 Early Gestational Diabetes Screening in the Gravid Obese Woman
Gestational Diabetes · Obesity
Primary: Number of Participants With a Composite Perinatal Outcome — 235; 261 Participants
N/A N=35 Diabetes Prevention Program Feasibility Study of Breastfeeding
Pregnancy · Overweight and Obesity
Primary: Change in Weight — 7.5; 13.4; 18.2; -5.6 kgs
N/A N=60 Effect of Fibre Supplements on Gestational Diabetes
Gestational Diabetes
Primary: Numbers Diagnosed With Gestational Diabetes — 7; 6 Participants — p=0.639
N/A N=50 Postpartum Continuous Glucose Monitoring (CGM) Study
Gestational Diabetes
Primary: Number of Participants With at Least 72 Hours of CGM Data Downloaded. — 43 Participants
N/A N=6,588 Comparison of Outreach Methods to Encourage Enrollment in Diabetes Prevention and Weight Management Programs
PreDiabetes · Obesity
Primary: Enrollment in Diabetes Prevention or Weight Management Class (Online) — 7; 12; 39; 59 Participants — p=<0.001
N/A N=435 A Co-created Self-care and Informal Support Intervention Study Among Women With GDM in Vietnam
GDM
Primary: Large for Gestational Age (LGA) — 23; 17 Participants
N/A N=106 Lipid Metabolism in Gestational Diabetes
Gestational Diabetes · Hyperlipidemia
Primary: Cholesterol — 204; 201 mg/dl
N/A N=62 Evaluating a Type 2 Diabetes Prevention Program
Type 2 Diabetes · PreDiabetes
Primary: Body Mass Index (BMI) - Post-Test — 30.3; 28.8 kg/m2
N/A N=921 Comparison of Two Screening Strategies for Gestational Diabetes (GDM2)
Gestational Diabetes · Pregnancy · Glucose Intolerance
Primary: Large for Gestational Age (LGA) Infant — 34; 35; 28; 34 Participants — p=0.668
N/A N=148 Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women
Diabetes
Primary: Gestational Weight Gain — 7.9; 10.4 kg
Phase 4 N=182 Evaluation of a Primary Type 2 Diabetes Prevention Programme
Diabetes Mellitus
Primary: Weight Change — -3.8; -1.4 kg — p=<.05
N/A N=72 Feasibility of a Partnered Approach to Prevent Diabetes
Pre-diabetic State · Overweight · Obesity
Primary: Weight Loss — 4.37; 3.23 kilograms
N/A N=55 Eating Disorder Prevention Program for Women With T1D
Eating Disorders · Type 1 Diabetes
Primary: Percentage of Time With Blood Sugar in Range as a Measure of Glycemic Control — 0.61; 0.63 percentage of time
N/A N=10 The Virtual Visit for Women With Gestational Diabetes
Diabetes, Gestational
Primary: Compliance With Requirements for Frequency of Glucose Measures — 3.1 number of glucose checks per pt per day
N/A N=223 Diabetes Prevention Translation: the Healthy Lifestyle Project
Diabetes · Cardiovascular Risk Factor
Primary: Changes in Weight Between Baseline and Post-intervention (Assessed at 6 Months After Commencement of Intervention) Compared to Delayed Intervention Participants…
N/A N=118 Weight Management for Improved Pregnancy Outcomes
Obesity · Pregnancy
Primary: Maternal Weight Change — 1.2; -2.6 kg
N/A N=814 Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy
Gestational Diabetes
Primary: Number of Neonates That Show Composite Adverse Neonatal Outcome — 130; 114 Participants
N/A N=483 Presessions for the National Diabetes Prevention Program
Prediabetic State · Obesity · Gestational Diabetes
Primary: Weight Loss — 3.1; 2.8 % of weight loss
Phase 2 N=31 Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes
Non Insulin Dependent Diabetes · Pregnancy
Primary: Blood Glucose Measurements — 97.38; 95.04; 97.00; 92.38 mg/dL